Literature DB >> 26208638

KCNK1 inhibits osteoclastogenesis by blocking the Ca2+ oscillation and JNK-NFATc1 signaling axis.

Jeong-Tae Yeon1, Kwang-Jin Kim2, Sang Woo Chun3, Hae In Lee3, Ji Yeon Lim4, Young-Jin Son2, Seong Hwan Kim5, Sik-Won Choi5.   

Abstract

KCNK1 (K(+) channel, subfamily K, member 1) is a member of the inwardly rectifying K(+) channel family, which drives the membrane potential towards the K(+) balance potential. Here, we investigated its functional relevance during osteoclast differentiation. KCNK1 was significantly induced during osteoclast differentiation, but its functional overexpression significantly inhibited osteoclast differentiation induced by RANKL (also known as TNFSF11), which was accompanied by the attenuation of the RANKL-induced Ca(2+) oscillation, JNK activation and NFATc1 expression. In contrast, KCNK1 knockdown enhanced the RANKL-induced osteoclast differentiation, JNK activation and NFATc1 expression. In conclusion, we suggest that KCNK1 is a negative regulator of osteoclast differentiation; the increase of K(+) influx by its functional blockade might inhibit osteoclast differentiation by inhibiting Ca(2+) oscillation and the JNK-NFATc1 signaling axis. Together with the increased attention on the pharmacological possibilities of using channel inhibition in the treatment of osteoclast-related disorders, further understanding of the functional roles and mechanisms of K(+) channels underlying osteoclast-related diseases could be helpful in developing relevant therapeutic strategies.
© 2015. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Ca2+; JNK; K+ channel; KCNK1; NFATc1; Osteoclast

Mesh:

Substances:

Year:  2015        PMID: 26208638     DOI: 10.1242/jcs.170738

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  4 in total

1.  6-Shogaol promotes bone resorption and accelerates orthodontic tooth movement through the JNK-NFATc1 signaling axis.

Authors:  Xiaofang Zhu; Hao Yuan; Ouyang Ningjuan; Carroll Ann Trotman; Thomas E Van Dyke; Jake Jinkun Chen; Guofang Shen
Journal:  J Bone Miner Metab       Date:  2021-06-30       Impact factor: 2.626

2.  Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: Implication for the treatment of postmenopausal bone loss.

Authors:  Donatella Granchi; Elena Torreggiani; Annamaria Massa; Renata Caudarella; Gemma Di Pompo; Nicola Baldini
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

3.  Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption.

Authors:  Chenguang Niu; Fei Xiao; Keyong Yuan; XuChen Hu; Wenzhen Lin; Rui Ma; Xiaoling Zhang; Zhengwei Huang
Journal:  Front Pharmacol       Date:  2017-09-12       Impact factor: 5.810

4.  Barley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of Osteoclastogenesis.

Authors:  Sik-Won Choi; Shin-Hye Kim; Kwang-Sik Lee; Hyeon Jung Kang; Mi Ja Lee; Kie-In Park; Jin Hwan Lee; Ki Do Park; Woo Duck Seo
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-08       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.